MEDCIS AS
Operating
Utvikle medisinske kommunikasjons- og informasjonssystemer. Selskapet
kan i tillegg levere konsulenttjenester innen fagene medisin, biologi
og informasjonsteknologi. Selskapet kan også delta som aksjonær eller
på annen måte ved investering i andre virksomheter.
Konsulentverksemd innan faga medisin, bioteknologi
og miljøvern og det som har høyrer inn under
dette. Selskapet kan og delta som aksjonær, eller
på anna måte ved investering i andre verksemder.
Organization
- CEO
- DH
Dag Hjelle1959
- Chairman of the board
- DH
Dag Hjelle1959
- Years since formation
- 31 years
- since Feb 19, 1995
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 140
- 1 share class
- Total number of shareholders
- 1
- person
- Belongs to group of
Financials
- Total operating income 2025
- 481,172
- NOK
- Annual total result 2025
- -6,279
- NOK
- Total equity 2025
- 215,685
- NOK
Last update: Jun 22, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
DH 1959 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
DH 1959 | Chairman | 100 % directly |
BH 1939 | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
DH 1959 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
DH 1959 | Ordinary shares | 140 | 100 % |
Shares owned by the MEDCIS AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 200 | 100 % | |
| Ordinary shares | 40,000 | 33.33 % | |
| Ordinary shares | 660 | 20 % | |
| NO0010098247 | 288 | < 0.01 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 481,172Operating profit 2025: NOK -6,113Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 481,172 | 402,730 | 468,675 | 821,635 | 668,887 |
Annual Total Result | -6,279 | -145,479 | 69,353 | 551,841 | 201,202 |
Total assets | 1,135,256 | 650,074 | 843,522 | 854,140 | 1,052,586 |
Total liabilities | 919,571 | 428,110 | 476,079 | 556,050 | 1,306,337 |
Total equity | 215,685 | 221,964 | 367,443 | 298,090 | -253,751 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 481,172 | 402,730 | 468,675 | 821,635 | 668,887 |
Total operating costs | 487,285 | 330,834 | 392,472 | 227,487 | 432,050 |
Operating result | -6,113 | 71,896 | 76,203 | 594,149 | 236,836 |
Financial income/costs | -165 | -201,461 | 12,802 | -15,621 | -35,635 |
Profit before tax | -6,279 | -129,565 | 89,005 | 578,527 | 201,202 |
Total tax & extraordinary income/cost | 0 | 15,914 | 19,652 | 26,686 | 0 |
Annual Total Result | -6,279 | -145,479 | 69,353 | 551,841 | 201,202 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 942,572 | 620,572 | 775,201 | 569,501 | 536,501 |
Total current assets | 192,684 | 29,502 | 68,321 | 284,640 | 516,085 |
Total assets | 1,135,256 | 650,074 | 843,522 | 854,140 | 1,052,586 |
Short term debt | 919,571 | 428,110 | 476,079 | 556,050 | 1,306,337 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 919,571 | 428,110 | 476,079 | 556,050 | 1,306,337 |
Contributed capital | 140,000 | 140,000 | 140,000 | 140,000 | 140,000 |
Retained earnings | 75,685 | 81,964 | 227,443 | 158,090 | -393,751 |
Total equity | 215,685 | 221,964 | 367,443 | 298,090 | -253,751 |
Total equity and liabilities | 1,135,256 | 650,074 | 843,522 | 854,140 | 1,052,586 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises